1,8-Naphthyridine,5-[3-(2-methyl-2H-tetrazol-5-yl)phenyl]-2-(trifluoromethyl)- (488799-23-1)

Identification
Name:	1,8-Naphthyridine,5-[3-(2-methyl-2H-tetrazol-5-yl)phenyl]-2-(trifluoromethyl)-
CAS:	488799-23-1
Molecular Formula:	C₁₇H₁₁F₃N₆
Molecular Structure:
Properties
Safety Data

Other Product

1H-1-Benzazepin-5-amine,N-[[3-chloro-5-(trifluoromethyl)phenyl]methyl]-1-(cyclopropylmethyl)-2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-N-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,N-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]-2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-1-(4-pyridinylmethyl)-N-[[3-(trifluoromethoxy)phenyl]methyl]-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2,3,4,5-tetrahydro-7-methyl-1-(1-methylethyl)-N-(2-methyl-2H-tetrazol-5-yl)-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,1-acetyl-N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-1-(cyclohexylcarbonyl)-2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-8-(trifluoromethyl)-,(5S)-
1H-1-Benzazepin-5-amine,N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-1-(4-piperidinyl)-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-9-bromo-2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2,3,4,5-tetrahydro-7,9-dimethyl-N-(2-methyl-2H-tetrazol-5-yl)-1-(4-pyridinylmethyl)-8-(trifluoromethyl)-,(5S)-
1H-1-Benzazepin-5-amine,N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-1-ethyl-2,3,4,5-tetrahydro-7,9-dimethyl-N-(2-methyl-2H-tetrazol-5-yl)-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2,3,4,5-tetrahydro-7,9-dimethyl-N-(2-methyl-2H-tetrazol-5-yl)-1-(4-piperidinylmethyl)-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,N-[2-(2-aminoethyl)-2H-tetrazol-5-yl]-N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-1-(cyclopropylmethyl)-2,3,4,5-tetrahydro-7,9-dimethyl-8-(trifluoromethyl)-, (5S)-
1H-1-Benzazepin-5-amine,2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-1-(4-pyridinylmethyl)-8-(trifluoromethyl)-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]-,(5S)-
1H-1-Benzazepine-1-carboxylic acid,2,3,4,5-tetrahydro-7-methyl-5-[(2-methyl-2H-tetrazol-5-yl)[[3-methyl-5-(trifluoromethyl)phenyl]methyl]amino]-8-(trifluoromethyl)-, 1,1-dimethylethylester, (5S)-
1H-1-Benzazepin-5-amine,2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-N-[[3-methyl-5-(trifluoromethyl)phenyl]methyl]-1-(4-pyridinylmethyl)-8-(trifluoromethyl)-,(5S)-
1H-1-Benzazepin-5-amine,N-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]-2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-1-(4-pyridinylmethyl)-8-(trifluoromethyl)-,(5S)-
1H-1-Benzazepin-5-amine,N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2,3,4,5-tetrahydro-7-methyl-N-(2-methyl-2H-tetrazol-5-yl)-1-(1H-tetrazol-5-ylmethyl)-8-(trifluoromethyl)-,(5S)-
2H-1-Benzopyran-2-one,6-methyl-8-(1-methylethoxy)-3-(2H-tetrazol-5-yl)-